Marquette General Hospital Acute Care Hospital (Medicare Certified) Location: 850 W Baraga Ave, Marquette, Michigan 49855 Ratings: Phone: (906) 228-9440 |
News Archive
Is the human immune system similar to the weather, a seemingly random yet dynamical system that can be modeled based on past conditions to predict future states? Scientists at VCU Massey Cancer Center's award-winning Bone Marrow Transplant (BMT) Program believe it is, and they recently published several studies that support the possibility of using next-generation DNA sequencing and mathematical modeling to not only understand the variability observed in clinical outcomes of stem cell transplantation, but also to provide a theoretical framework to make transplantation a possibility for more patients who do not have a related donor.
Whether mom's golden child or her black sheep, siblings who sense that their mother consistently favors or rejects one child over others are more likely to show depressive symptoms as middle-aged adults - according to a new study by Cornell University gerontologist Karl
Rare deletions at chromosome 22q11.2 are present at an increased rate in patients with Parkinson's disease, researchers report in The Lancet Neurology.
The Lupus Foundation of America (LFA) seeks grant applications to advance the science and medicine of lupus and to help improve the quality of lives of all people affected by this disease. The LFA is seeking grant applications to address the following areas of lupus research: cutaneous (skin) lupus, pediatric lupus, adult stem cell transplantation, and neuropsychiatric lupus, which affects the brain and nervous system.
Synta Pharmaceuticals Corp. today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms' tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.
› Verified 7 days ago